Technology made to speed up, increase
the success ratio and profitability of
Drug Design and Enzyme Engineering
Unique Monte Carlo based biomolecular modeling tools for all kind of early drug discovery and enzyme engineering programs.ACCESS TECHNOLOGIES
Forged in recognised academic groups, 75% of the company has a PhD with long and reputed experience working with clients.ACCESS TEAM
NUCLEIC ACIDSACCESS DIVISIONS
- Non-propietary Software
- Artificial Inteligence
- ED/MD Suite
Click on technologies to show their divisions
Emerging trends: Covalent inhibitors
With over 50 approved drugs currently on the market, covalent inhibitors seem to be a hot topic! Find out what all the fuss is about and we’re doing to stay on top of things.
Javier Iglesias appointed as new Division Leader of the Enzyme Engineering division
Dr. Iglesias, who recently joined NBD as Project Manager for the Nucleic Acids Division, has been internally promoted to substitute the...
Check the new article of our worker Joan Coines, in which he engineered a glycosyltransferase able to efficiently catalyze N-, O-, or S-glycosylation. More #enzymeengineering expertise on board!